{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:01:59Z","timestamp":1784592119879,"version":"3.55.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["722619"],"award-info":[{"award-number":["722619"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018693","name":"HORIZON EUROPE Framework Programme","doi-asserted-by":"publisher","award":["101080329"],"award-info":[{"award-number":["101080329"]}],"id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]},{"name":"PRIMA","award":["CUP H93C22000950001"],"award-info":[{"award-number":["CUP H93C22000950001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s11739-025-04090-3","type":"journal-article","created":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T13:29:47Z","timestamp":1758547787000},"page":"1655-1661","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Tango between obesogenic environment and metabolic dysfunction-associated steatotic liver disease (MASLD): shifting towards earlier detection"],"prefix":"10.1007","volume":"20","author":[{"given":"Harshitha","family":"Shanmugam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agostino","family":"Di Ciaula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5359-1471","authenticated-orcid":false,"given":"Piero","family":"Portincasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,22]]},"reference":[{"key":"4090_CR1","doi-asserted-by":"publisher","DOI":"10.1111\/eci.70059","author":"F Carbone","year":"2025","unstructured":"Carbone F, Despres JP, Ioannidis JPA et al (2025) Bridging the gap in obesity research: a consensus statement from the European Society for Clinical Investigation. Eur J Clin Invest. https:\/\/doi.org\/10.1111\/eci.70059","journal-title":"Eur J Clin Invest"},{"issue":"10481","key":"4090_CR2","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/S0140-6736(25)00355-1","volume":"405","author":"GBD 2021 Adult BMI Collaborators","year":"2025","unstructured":"GBD 2021 Adult BMI Collaborators. Global, regional, and national prevalence of adult overweight and obesity, 1990\u20132021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021. Lancet 405(10481):813\u2013838. https:\/\/doi.org\/10.1016\/S0140-6736(25)00355-1","journal-title":"Lancet"},{"key":"4090_CR3","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ejim.2024.04.013","volume":"124","author":"P Portincasa","year":"2024","unstructured":"Portincasa P, Baffy G (2024) Metabolic dysfunction-associated steatotic liver disease: evolution of the final terminology. Eur J Intern Med 124:35\u201339. https:\/\/doi.org\/10.1016\/j.ejim.2024.04.013","journal-title":"Eur J Intern Med"},{"issue":"4","key":"4090_CR4","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","volume":"77","author":"ZM Younossi","year":"2023","unstructured":"Younossi ZM, Golabi P, Paik JM, Henry A, Van Dongen C, Henry L (2023) The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology 77(4):1335\u20131347. https:\/\/doi.org\/10.1097\/HEP.0000000000000004","journal-title":"Hepatology"},{"issue":"9","key":"4090_CR5","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1111\/j.1572-0241.1999.01377.x","volume":"94","author":"EM Brunt","year":"1999","unstructured":"Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR (1999) Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 94(9):2467\u20132474. https:\/\/doi.org\/10.1111\/j.1572-0241.1999.01377.x","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"4090_CR6","doi-asserted-by":"publisher","first-page":"e2407","DOI":"10.1210\/clinem\/dgaf094","volume":"110","author":"A Gastaldelli","year":"2025","unstructured":"Gastaldelli A, Newsome PN (2025) NAFLD vs MASLD (metabolic dysfunction-associated steatotic liver disease)-why the need for a change of nomenclature? J Clin Endocrinol Metab 110(7):e2407\u2013e2410. https:\/\/doi.org\/10.1210\/clinem\/dgaf094","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"4090_CR7","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","volume":"73","author":"M Eslam","year":"2020","unstructured":"Eslam M, Newsome PN, Sarin SK et al (2020) A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol 73(1):202\u2013209. https:\/\/doi.org\/10.1016\/j.jhep.2020.03.039","journal-title":"J Hepatol"},{"key":"4090_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.06.003","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V et al (2023) A multi-society Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. https:\/\/doi.org\/10.1016\/j.jhep.2023.06.003","journal-title":"J Hepatol"},{"issue":"3","key":"4090_CR9","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/s41575-025-01046-y","volume":"22","author":"Editorial","year":"2025","unstructured":"Editorial (2025) Reframing obesity and MASLD. Nat Rev Gastroenterol Hepatol 22(3):147\u2013147. https:\/\/doi.org\/10.1038\/s41575-025-01046-y","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"4090_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2025.05.018","author":"H Abdallah","year":"2025","unstructured":"Abdallah H, Khalil M, Awada E, Lanza E, Di Ciaula A, Portincasa P (2025) Metabolic dysfunction-associated steatotic liver disease (MASLD). Assessing metabolic dysfunction, cardiovascular risk factors, and lifestyle habits. Eur J Intern Med. https:\/\/doi.org\/10.1016\/j.ejim.2025.05.018","journal-title":"Eur J Intern Med"},{"issue":"4","key":"4090_CR11","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1097\/HEP.0000000000000383","volume":"78","author":"P Hartmann","year":"2023","unstructured":"Hartmann P, Zhang X, Loomba R, Schnabl B (2023) Global and national prevalence of nonalcoholic fatty liver disease in adolescents: an analysis of the global burden of disease study 2019. Hepatology 78(4):1168\u20131181. https:\/\/doi.org\/10.1097\/HEP.0000000000000383","journal-title":"Hepatology"},{"issue":"6","key":"4090_CR12","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.14309\/ajg.0000000000003278","volume":"120","author":"Y Qiao","year":"2024","unstructured":"Qiao Y, Yang L, Yang H, Zheng M, Zhao M, Xi B (2024) Longitudinal associations between metabolic dysfunction-associated steatotic liver disease and subclinical cardiovascular measures in Chinese children. Am J Gastroenterol 120(6):1395\u20131399. https:\/\/doi.org\/10.14309\/ajg.0000000000003278","journal-title":"Am J Gastroenterol"},{"key":"4090_CR13","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000001357","author":"JB Schwimmer","year":"2025","unstructured":"Schwimmer JB, Thai NQN, Noon SL et al (2025) Long-term mortality and extrahepatic outcomes in 1096 children with MASLD: a retrospective cohort study. Hepatology. https:\/\/doi.org\/10.1097\/HEP.0000000000001357","journal-title":"Hepatology"},{"key":"4090_CR14","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13682","author":"A Di Ciaula","year":"2021","unstructured":"Di Ciaula A, Krawczyk M, Filipiak KJ, Geier A, Bonfrate L, Portincasa P (2021) Noncommunicable diseases, climate change and iniquities: what COVID-19 has taught us about syndemic. Eur J Clin Invest. https:\/\/doi.org\/10.1111\/eci.13682","journal-title":"Eur J Clin Invest"},{"issue":"8","key":"4090_CR15","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1007\/s11739-022-03107-5","volume":"17","author":"A Di Ciaula","year":"2022","unstructured":"Di Ciaula A, Moshammer H, Lauriola P, Portincasa P (2022) Environmental health, COVID-19, and the syndemic: internal medicine facing the challenge. Intern Emerg Med 17(8):2187\u20132198. https:\/\/doi.org\/10.1007\/s11739-022-03107-5","journal-title":"Intern Emerg Med"},{"issue":"19","key":"4090_CR16","doi-asserted-by":"publisher","first-page":"3471","DOI":"10.2174\/0929867324666170518095736","volume":"26","author":"A Di Ciaula","year":"2019","unstructured":"Di Ciaula A, Portincasa P (2019) Diet and contaminants: driving the rise to obesity epidemics? Curr Med Chem 26(19):3471\u20133482. https:\/\/doi.org\/10.2174\/0929867324666170518095736","journal-title":"Curr Med Chem"},{"issue":"2","key":"4090_CR17","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s11739-024-03559-x","volume":"19","author":"A Di Ciaula","year":"2024","unstructured":"Di Ciaula A, Portincasa P (2024) Contrasting obesity: is something missing here? Intern Emerg Med 19(2):265\u2013269. https:\/\/doi.org\/10.1007\/s11739-024-03559-x","journal-title":"Intern Emerg Med"},{"issue":"2","key":"4090_CR18","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S2213-8587(25)00004-X","volume":"13","author":"E The Lancet Diabetes & Endocrinology","year":"2025","unstructured":"The Lancet Diabetes & Endocrinology\u00a0(2025) Redefining obesity: advancing care for better lives. Lancet Diabetes Endocrinol 13(2):75. https:\/\/doi.org\/10.1016\/S2213-8587(25)00004-X","journal-title":"Lancet Diabetes Endocrinol"},{"key":"4090_CR19","doi-asserted-by":"publisher","DOI":"10.1111\/apt.70020","author":"ZM Younossi","year":"2025","unstructured":"Younossi ZM, Razavi H, Sherman M et al (2025) Addressing the high and rising global burden of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH): from the growing prevalence to payors\u2019 perspective. Aliment Pharmacol Ther. https:\/\/doi.org\/10.1111\/apt.70020","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"4090_CR20","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1097\/HEP.0000000000000411","volume":"78","author":"JV Lazarus","year":"2023","unstructured":"Lazarus JV, Kopka CJ, Younossi ZM, Allen AM (2023) It is time to expand the fatty liver disease community of practice. Hepatology 78(5):1325\u20131328. https:\/\/doi.org\/10.1097\/HEP.0000000000000411","journal-title":"Hepatology"},{"key":"4090_CR21","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab399","author":"PJ Oliveira","year":"2021","unstructured":"Oliveira PJ (2021) The heart of FOIE GRAS and mtFOIE GRAS: fundamental and clinical investigation for training and innovation in non-alcoholic fatty liver disease. Eur Heart J. https:\/\/doi.org\/10.1093\/eurheartj\/ehab399","journal-title":"Eur Heart J"},{"key":"4090_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-025-03721-8","author":"AN Malik","year":"2025","unstructured":"Malik AN, Azul AM, Carvalho E, Jones JG, Matafome P, Oliveira PJ, Consortium PG (2025) Tackling overweight and obesity in the youth with the PAS GRAS project. Nat Med. https:\/\/doi.org\/10.1038\/s41591-025-03721-8","journal-title":"Nat Med"},{"issue":"1","key":"4090_CR23","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s11739-024-03776-4","volume":"20","author":"A Di Ciaula","year":"2025","unstructured":"Di Ciaula A (2025) Non-invasive phenotyping of fatty liver: clues for management and prevention. Intern Emerg Med 20(1):7\u20138. https:\/\/doi.org\/10.1007\/s11739-024-03776-4","journal-title":"Intern Emerg Med"},{"issue":"2","key":"4090_CR24","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1053\/j.gastro.2024.03.017","volume":"167","author":"LA van Kleef","year":"2024","unstructured":"van Kleef LA, Francque SM, Prieto-Ortiz JE et al (2024) Metabolic dysfunction-associated fibrosis 5 (MAF-5) score predicts liver fibrosis risk and outcome in the general population with metabolic dysfunction. Gastroenterology 167(2):357\u2013367. https:\/\/doi.org\/10.1053\/j.gastro.2024.03.017","journal-title":"Gastroenterology"},{"key":"4090_CR25","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ejim.2024.03.004","volume":"125","author":"S Santoro","year":"2024","unstructured":"Santoro S, Khalil M, Abdallah H et al (2024) Early and accurate diagnosis of steatotic liver by artificial intelligence (AI)-supported ultrasonography. Eur J Intern Med 125:57\u201366. https:\/\/doi.org\/10.1016\/j.ejim.2024.03.004","journal-title":"Eur J Intern Med"},{"issue":"7","key":"4090_CR26","doi-asserted-by":"publisher","first-page":"3564","DOI":"10.1007\/s00330-019-06072-4","volume":"29","author":"J Gu","year":"2019","unstructured":"Gu J, Liu S, Du S, Zhang Q, Xiao J, Dong Q, Xin Y (2019) Diagnostic value of MRI-PDFF for hepatic steatosis in patients with non-alcoholic fatty liver disease: a meta-analysis. Eur Radiol 29(7):3564\u20133573. https:\/\/doi.org\/10.1007\/s00330-019-06072-4","journal-title":"Eur Radiol"},{"issue":"5","key":"4090_CR27","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1002\/hep.31599","volume":"73","author":"EM Brunt","year":"2021","unstructured":"Brunt EM, Kleiner DE, Carpenter DH et al (2021) NAFLD: reporting histologic findings in clinical practice. Hepatology 73(5):2028\u20132038. https:\/\/doi.org\/10.1002\/hep.31599","journal-title":"Hepatology"},{"issue":"8","key":"4090_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0182784","volume":"12","author":"BG Jun","year":"2017","unstructured":"Jun BG, Park WY, Park EJ et al (2017) A prospective comparative assessment of the accuracy of the FibroScan in evaluating liver steatosis. PLoS ONE 12(8):e0182784. https:\/\/doi.org\/10.1371\/journal.pone.0182784","journal-title":"PLoS ONE"},{"issue":"4","key":"4090_CR29","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.cgh.2018.05.059","volume":"17","author":"C Hsu","year":"2019","unstructured":"Hsu C, Caussy C, Imajo K et al (2019) Magnetic resonance vs transient elastography analysis of patients with nonalcoholic fatty liver disease: a systematic review and pooled analysis of individual participants. Clin Gastroenterol Hepatol 17(4):630-637.e638. https:\/\/doi.org\/10.1016\/j.cgh.2018.05.059","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"4090_CR30","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","volume":"77","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Neuschwander-Tetri BA, Siddiqui MS, Abdelmalek MF, Caldwell S, Barb D, Kleiner DE, Loomba R (2023) Aasld practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology 77(5):1797\u20131835. https:\/\/doi.org\/10.1097\/HEP.0000000000000323","journal-title":"Hepatology"},{"issue":"1","key":"4090_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2020.100203","volume":"3","author":"E Molina-Molina","year":"2021","unstructured":"Molina-Molina E, Shanmugam H, Di Ciaula A, Grattagliano I, Di Palo DM, Palmieri VO, Portincasa P (2021) (13C)-Methacetin breath test provides evidence of subclinical liver dysfunction linked to fat storage but not lifestyle. JHEP Rep 3(1):100203. https:\/\/doi.org\/10.1016\/j.jhepr.2020.100203","journal-title":"JHEP Rep"},{"key":"4090_CR32","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.ejim.2022.10.024","volume":"107","author":"A Di Ciaula","year":"2023","unstructured":"Di Ciaula A, Shanmugam H, Ribeiro R, Pina A, Andrade R, Bonfrate L, Raposo JF, Macedo MP, Portincasa P (2023) Liver fat accumulation more than fibrosis causes early liver dynamic dysfunction in patients with non-alcoholic fatty liver disease. Eur J Intern Med 107:52\u201359. https:\/\/doi.org\/10.1016\/j.ejim.2022.10.024","journal-title":"Eur J Intern Med"},{"issue":"6","key":"4090_CR33","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1016\/j.jhep.2022.08.028","volume":"77","author":"EK Mitten","year":"2022","unstructured":"Mitten EK, Baffy G (2022) Mechanotransduction in the pathogenesis of non-alcoholic fatty liver disease. J Hepatol 77(6):1642\u20131656. https:\/\/doi.org\/10.1016\/j.jhep.2022.08.028","journal-title":"J Hepatol"},{"key":"4090_CR34","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ejim.2021.03.036","volume":"89","author":"A Di Ciaula","year":"2021","unstructured":"Di Ciaula A, Carbone F, Shanmugham H, Molina-Molina E, Bonfrate L, Ministrini S, Montecucco F, Portincasa P (2021) Adiponectin involved in portal flow hepatic extraction of 13C-methacetin in obesity and non-alcoholic fatty liver. Eur J Intern Med 89:56\u201364. https:\/\/doi.org\/10.1016\/j.ejim.2021.03.036","journal-title":"Eur J Intern Med"},{"issue":"8","key":"4090_CR35","doi-asserted-by":"publisher","DOI":"10.1111\/eci.14003","volume":"53","author":"A Di Ciaula","year":"2023","unstructured":"Di Ciaula A, Bonfrate L, Shanmugam H, Weber SN, Krawczyk M, Portincasa P (2023) Effects of MBOAT7 polymorphism and steatosis on liver function assessed by methacetin breath test. Eur J Clin Invest 53(8):e14003. https:\/\/doi.org\/10.1111\/eci.14003","journal-title":"Eur J Clin Invest"},{"issue":"7","key":"4090_CR36","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13597","volume":"51","author":"H Shanmugam","year":"2021","unstructured":"Shanmugam H, Di Ciaula A, Di Palo DM, Molina-Molina E, Garruti G, Faienza MF, vanErpecum K, Portincasa P (2021) Multiplying effects of COVID-19 lockdown on metabolic risk and fatty liver. Eur J Clin Invest 51(7):e13597. https:\/\/doi.org\/10.1111\/eci.13597","journal-title":"Eur J Clin Invest"},{"key":"4090_CR37","unstructured":"Sugar-sweetened beverage taxes in the WHO European Region: success through lessons learned and challenges faced [https:\/\/www.who.int\/europe\/publications\/i\/item\/WHO-EURO-2022-4781-44544-63081?ut]"},{"issue":"1","key":"4090_CR38","doi-asserted-by":"publisher","first-page":"2085121","DOI":"10.1080\/2474736X.2022.2085121","volume":"4","author":"S Schunz","year":"2022","unstructured":"Schunz S (2022) The \u2018European Green Deal\u2019 \u2013 a paradigm shift? Transformations in the European Union\u2019s sustainability meta-discourse. Polit Res Exch 4(1):2085121. https:\/\/doi.org\/10.1080\/2474736X.2022.2085121","journal-title":"Polit Res Exch"},{"issue":"6","key":"4090_CR39","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13901","volume":"26","author":"SP Mambrini","year":"2025","unstructured":"Mambrini SP, Penzavecchia C, Menichetti F et al (2025) Plant-based and sustainable diet: a systematic review of its impact on obesity. Obes Rev 26(6):e13901. https:\/\/doi.org\/10.1111\/obr.13901","journal-title":"Obes Rev"},{"issue":"10173","key":"4090_CR40","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/S0140-6736(18)32822-8","volume":"393","author":"BA Swinburn","year":"2019","unstructured":"Swinburn BA, Kraak VI, Allender S et al (2019) The global syndemic of obesity, undernutrition, and climate change: the Lancet commission report. Lancet 393(10173):791\u2013846. https:\/\/doi.org\/10.1016\/S0140-6736(18)32822-8","journal-title":"Lancet"},{"issue":"5","key":"4090_CR41","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1007\/s11739-024-03688-3","volume":"19","author":"A Di Ciaula","year":"2024","unstructured":"Di Ciaula A, Mannucci PM, Portincasa P (2024) Environmental health and clinicians: time to promote more action. Intern Emerg Med 19(5):1203\u20131207. https:\/\/doi.org\/10.1007\/s11739-024-03688-3","journal-title":"Intern Emerg Med"},{"issue":"5","key":"4090_CR42","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s11154-023-09798-1","volume":"24","author":"A Di Ciaula","year":"2023","unstructured":"Di Ciaula A, Bonfrate L, Khalil M, Garruti G, Portincasa P (2023) Contribution of the microbiome for better phenotyping of people living with obesity. Rev Endocr Metab Disord 24(5):839\u2013870. https:\/\/doi.org\/10.1007\/s11154-023-09798-1","journal-title":"Rev Endocr Metab Disord"}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-025-04090-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11739-025-04090-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-025-04090-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T15:20:26Z","timestamp":1758986426000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11739-025-04090-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["4090"],"URL":"https:\/\/doi.org\/10.1007\/s11739-025-04090-3","relation":{},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"value":"1828-0447","type":"print"},{"value":"1970-9366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"2 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors hereby affirm that there are no conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights statement"}},{"value":"No human\/animal data reported.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}